Jan 31, 2020, 4:05 PM
Slideshow on epigenetics which was presented at the Wellstone Research Update 2020 by Peter Jones PhD.
Jan 30, 2020, 8:58 AM
Fulcrum Therapeutics announced that the FDA has granted Orphan Drug Designation to losmapimod, a selective p38α/β mitogen activated protein kinase (MAPK) inhibitor.
Jan 28, 2020, 1:31 PM
Rashnonajad provides the initial progress update showing efficiently reduced DUX4 mRNA and consequently DUX4 protein in FSHD cells.
Jan 9, 2020, 10:37 AM
The Friends of FSH Research is partnering with the FSHD Society on a landmark Voice of the Patient Forum for Drug Development.